RecruitingNot ApplicableNCT07138287

Concerned Growth Factor VS Miniral Trioide Aggregate in Treatment of Mature Permanent Teeth of Children With Symptomatic Irreversible Pulpitis.

Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar of Children With Irreversible Pulpitis. An 18-month Randomized Control Trial

Sponsor

Minia University

Enrollment

200 participants

Start Date

Jul 11, 2025

Study Type

INTERVENTIONAL

Conditions

Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis

Summary

Concerned Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar of children with irreversible pulpitis

Eligibility

Min Age: 9 YearsMax Age: 16 Years

Inclusion Criteria1

Exclusion Criteria3

medically compromised children.
non restorable tooth
Necrotic tooth

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREConcerned Growth factor in management of Mature permanent Molar with irreversible pulpitis

Concerned Growth factor in management of Mature permanent Molar of children with irreversible pulpitis

Locations(1)

Minya University Faculty of Dentistry

Minya, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07138287